These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16893429

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Trimetazidine and cardioprotection: facts and perspectives.
    Tsioufis K, Andrikopoulos G, Manolis A.
    Angiology; 2015 Mar; 66(3):204-10. PubMed ID: 24719262
    [Abstract] [Full Text] [Related]

  • 27. Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice.
    Tang WH.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):999-1000. PubMed ID: 16949493
    [No Abstract] [Full Text] [Related]

  • 28. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
    Gunes Y, Tuncer M, Guntekin U, Akdag S, Gumrukcuoglu HA.
    Pacing Clin Electrophysiol; 2009 Feb 05; 32(2):239-44. PubMed ID: 19170914
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Can metabolic manipulation reverse myocardial dysfunction?
    Cokkinos DV.
    Eur Heart J; 2001 Dec 05; 22(23):2138-9. PubMed ID: 11913472
    [No Abstract] [Full Text] [Related]

  • 31. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y, Guntekin U, Tuncer M, Sahin M.
    Arq Bras Cardiol; 2009 Aug 05; 93(2):154-8. PubMed ID: 19838493
    [Abstract] [Full Text] [Related]

  • 32. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R, Solenghi M, Volpe L, Purcaro A.
    Eur Heart J; 2007 May 05; 28(9):1102-8. PubMed ID: 17456483
    [Abstract] [Full Text] [Related]

  • 33. [Metabolic therapy for heart failure].
    Loiacono F, Alberti L, Lauretta L, Puccetti P, Silipigni C, Margonato A, Fragasso G.
    Recenti Prog Med; 2014 May 05; 105(7-8):288-94. PubMed ID: 25072544
    [Abstract] [Full Text] [Related]

  • 34. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 05; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 35. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, Vinereanu D, Hamid MA, Jourdain P, Ponikowski P.
    Int J Cardiol; 2016 Jan 15; 203():909-15. PubMed ID: 26618252
    [Abstract] [Full Text] [Related]

  • 36. [Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure].
    Vasiuk IuA, Iushchuk EN, Shkol'nik EL, Khadzegova AB, Vit'ko NK, Vakhromeeva MN.
    Kardiologiia; 2006 Jan 15; 46(11):48-56. PubMed ID: 17159882
    [Abstract] [Full Text] [Related]

  • 37. Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
    Thrainsdottir IS, von Bibra H, Malmberg K, Rydén L.
    J Cardiovasc Pharmacol; 2004 Jul 15; 44(1):101-8. PubMed ID: 15175564
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.